Bookmark and Share

$MEDS Subsidiary Providing COVID-19 Antibody Testing for Commercial Property Firm in Atlanta

Trxade Group (NASDAQ: MEDS) and its wholly owned subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus Antibody Testing’. The article reports that commercial property firm Lee & Associates Atlanta will be one of the first Atlanta-based firms to reopen. The firm is working with Saidcard and Integra Pharma Solutions to ensure its employees will be tested for the COVID-19 antibodies. These antibodies “show if you had a previous infection with the virus,” according to the Centers for Disease Control and Prevention (“CDC”). The CDC also stated that it is unclear if the antibodies provide immunity from getting infected again. “We are working to ensure that all of the test kits we are providing our customers through Integra Pharma are sourced from manufacturers that have submitted an emergency use authorization with the [Food & Drug Administration],” Saidcard Chief Operating Officer Jo Ram said in a statement. “Additionally, as we roll this offering out to our customers, if a person tests positive for antibodies, we follow it up with a PCR test to see if they currently have the virus and need to be quarantined, or are virus free and can go back to work.”

To view the full article, visit http://nnw.fm/R9vOd

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy-delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, May 21st, 2020 News